Skip to main content
Previous
Poster Home
Next
Update From the Dedalo Protocol: An Integrated Approach to MRD in CLL Patients Receiving Venetoclax Plus Rituximab
07:30am - 03:45pm EST - April 1, 2023
Information
Resources
https://jnccn.org/view/journal...
Author(s):
Fabrizio Mavilia, MD
, University of Pisa School of Medicine and Surgery
Tags:
Clinical Oncology
Display Label
Action